Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway.

Rossato E, Ben Mkaddem S, Kanamaru Y, Hurtado-Nedelec M, Hayem G, Descatoire V, Vonarburg C, Miescher S, Zuercher AW, Monteiro RC.

Arthritis Rheumatol. 2015 Jul;67(7):1766-77. doi: 10.1002/art.39142.

2.

High-protein diet differently modifies intestinal goblet cell characteristics and mucosal cytokine expression in ileum and colon.

Lan A, Andriamihaja M, Blouin JM, Liu X, Descatoire V, Desclée de Maredsous C, Davila AM, Walker F, Tomé D, Blachier F.

J Nutr Biochem. 2015 Jan;26(1):91-8. doi: 10.1016/j.jnutbio.2014.09.007. Epub 2014 Oct 13.

PMID:
25459886
3.

Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability.

Thoury A, Descatoire V, Kotelevets L, Kannengiesser C, Bertrand G, Theou-Anton N, Frey C, Genestie C, Raymond E, Chastre E, Lehy T, Walker F.

Histol Histopathol. 2014 Nov;29(11):1455-66. doi: 10.14670/HH-29.1455. Epub 2014 May 8.

PMID:
24811063
4.

Overexpression of gastric leptin precedes adipocyte leptin during high-fat diet and is linked to 5HT-containing enterochromaffin cells.

Le Beyec J, Pelletier AL, Arapis K, Hourseau M, Cluzeaud F, Descatoire V, Ducroc R, Aparicio T, Joly F, Couvelard A, Marmuse JP, Le Gall M, Bado A.

Int J Obes (Lond). 2014 Oct;38(10):1357-64. doi: 10.1038/ijo.2014.14. Epub 2014 Jan 28.

PMID:
24468700
5.

Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue.

Albert S, Hourseau M, Halimi C, Serova M, Descatoire V, Barry B, Couvelard A, Riveiro ME, Tijeras-Raballand A, de Gramont A, Raymond E, Faivre S.

Oral Oncol. 2012 Dec;48(12):1263-71. doi: 10.1016/j.oraloncology.2012.06.010. Epub 2012 Jul 7.

PMID:
22776129
6.

Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.

Voisin T, El Firar A, Fasseu M, Rouyer-Fessard C, Descatoire V, Walker F, Paradis V, Bedossa P, Henin D, Lehy T, Laburthe M.

Cancer Res. 2011 May 1;71(9):3341-51. doi: 10.1158/0008-5472.CAN-10-3473. Epub 2011 Mar 17.

7.

Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen.

Knockaert L, Descatoire V, Vadrot N, Fromenty B, Robin MA.

Toxicol In Vitro. 2011 Mar;25(2):475-84. doi: 10.1016/j.tiv.2010.11.019. Epub 2010 Dec 2.

PMID:
21130154
8.

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.

Walker F, Abramowitz L, Benabderrahmane D, Duval X, Descatoire V, Hénin D, Lehy T, Aparicio T.

Hum Pathol. 2009 Nov;40(11):1517-27. doi: 10.1016/j.humpath.2009.05.010. Epub 2009 Aug 27.

PMID:
19716155
9.

Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation.

Robin MA, Descatoire V, Pessayre D, Berson A.

Toxicol In Vitro. 2008 Sep;22(6):1511-9. doi: 10.1016/j.tiv.2008.05.009. Epub 2008 Jul 7.

PMID:
18603402
10.

Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation.

Cazanave S, Vadrot N, Tinel M, Berson A, Lettéron P, Larosche I, Descatoire V, Feldmann G, Robin MA, Pessayre D.

Toxicol Appl Pharmacol. 2008 Sep 15;231(3):336-43. doi: 10.1016/j.taap.2008.05.010. Epub 2008 May 20.

PMID:
18572215
11.

High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.

Igoudjil A, Massart J, Begriche K, Descatoire V, Robin MA, Fromenty B.

Toxicol In Vitro. 2008 Jun;22(4):887-98. doi: 10.1016/j.tiv.2008.01.011. Epub 2008 Jan 26.

PMID:
18299183
12.

In vitro study of lovastatin interactions with amiodarone and with carbon tetrachloride in isolated rat hepatocytes.

Krasteva AZ, Mitcheva MK, Kondeva-Burdina MS, Descatoire VA.

World J Gastroenterol. 2007 Apr 21;13(15):2198-204.

13.

Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression.

Hreiche R, Mégarbane B, Pirnay S, Borron SW, Monier C, Risède P, Milan N, Descatoire V, Pessayre D, Baud FJ.

Toxicol Appl Pharmacol. 2006 Dec 15;217(3):352-62. Epub 2006 Sep 30.

PMID:
17084876
14.

Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells.

Daniel F, Legrand A, Pessayre D, Vadrot N, Descatoire V, Bernuau D.

World J Gastroenterol. 2006 May 14;12(18):2895-900.

15.

The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin.

Berson A, Cazanave S, Descatoire V, Tinel M, Grodet A, Wolf C, Feldmann G, Pessayre D.

J Pharmacol Exp Ther. 2006 Jul;318(1):444-54. Epub 2006 Apr 14.

PMID:
16617166
16.

Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes.

Robin MA, Sauvage I, Grandperret T, Descatoire V, Pessayre D, Fromenty B.

FEBS Lett. 2005 Dec 19;579(30):6895-902. Epub 2005 Dec 1.

17.

The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability.

Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, Pessayre D, Degoul F.

Pharmacogenet Genomics. 2005 May;15(5):311-9.

PMID:
15864132
18.

Subliminal Fas stimulation increases the hepatotoxicity of acetaminophen and bromobenzene in mice.

Tinel M, Berson A, Vadrot N, Descatoire V, Grodet A, Feldmann G, Thénot JP, Pessayre D.

Hepatology. 2004 Mar;39(3):655-66.

PMID:
14999684
19.

Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling.

Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M, Bado A.

J Biol Chem. 2004 Apr 16;279(16):16495-502. Epub 2004 Jan 29.

20.

Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver.

Mansouri A, Haouzi D, Descatoire V, Demeilliers C, Sutton A, Vadrot N, Fromenty B, Feldmann G, Pessayre D, Berson A.

Hepatology. 2003 Sep;38(3):715-25.

PMID:
12939598
21.

Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation.

Berson A, Descatoire V, Sutton A, Fau D, Maulny B, Vadrot N, Feldmann G, Berthon B, Tordjmann T, Pessayre D.

J Pharmacol Exp Ther. 2001 Nov;299(2):793-800.

PMID:
11602696
22.

Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation.

Berson A, Fau D, Fornacciari R, Degove-Goddard P, Sutton A, Descatoire V, Haouzi D, Lettéron P, Moreau A, Feldmann G, Pessayre D.

J Hepatol. 2001 Feb;34(2):261-9.

PMID:
11281555
23.

Vesicular transport of newly synthesized cytochromes P4501A to the outside of rat hepatocyte plasma membranes.

Robin MA, Descatoire V, Le Roy M, Berson A, Lebreton FP, Maratrat M, Ballet F, Loeper J, Pessayre D.

J Pharmacol Exp Ther. 2000 Sep;294(3):1063-9.

PMID:
10945860
24.

Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes.

Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V, Haouzi D, Berson A, Pessayre D.

J Pharmacol Exp Ther. 1999 May;289(2):649-55.

PMID:
10215635
25.

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis.

Robin MA, Le Roy M, Descatoire V, Pessayre D.

J Hepatol. 1997;26 Suppl 1:23-30. Review. No abstract available.

PMID:
9138125
26.

Hepatotoxicity of germander in mice.

Loeper J, Descatoire V, Letteron P, Moulis C, Degott C, Dansette P, Fau D, Pessayre D.

Gastroenterology. 1994 Feb;106(2):464-72.

PMID:
8299912
27.

Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies.

Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, Houssin D, Ballet F, Feldmann G, Guengerich FP, Pessayre D.

Gastroenterology. 1993 Jan;104(1):203-16.

PMID:
7678237
28.

Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane.

Loeper J, Descatoire V, Maurice M, Beaune P, Feldmann G, Larrey D, Pessayre D.

Hepatology. 1990 May;11(5):850-8.

PMID:
2112112
29.

Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses.

Letteron P, Labbe G, Descatoire V, Degott C, Loeper J, Tinel M, Larrey D, Pessayre D.

Biochem Pharmacol. 1989 Oct 1;38(19):3247-51.

PMID:
2818624
30.

Metabolic activation of the antidepressant tianeptine. I. Cytochrome P-450-mediated in vitro covalent binding.

Letteron P, Descatoire V, Tinel M, Maurel P, Labbe G, Loeper J, Larrey D, Freneaux E, Pessayre D.

Biochem Pharmacol. 1989 Oct 1;38(19):3241-6.

PMID:
2818623
31.

Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.

Labbe G, Descatoire V, Beaune P, Letteron P, Larrey D, Pessayre D.

J Pharmacol Exp Ther. 1989 Sep;250(3):1034-42.

PMID:
2506333
32.

Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.

Tinel M, Descatoire V, Larrey D, Loeper J, Labbe G, Letteron P, Pessayre D.

J Pharmacol Exp Ther. 1989 Aug;250(2):746-51.

PMID:
2527301
33.
34.

Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice.

Lettéron P, Degott C, Labbe G, Larrey D, Descatoire V, Tinel M, Pessayre D.

Toxicol Appl Pharmacol. 1987 Nov;91(2):266-73.

PMID:
3118512
35.

Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives.

Tinel M, Belghiti J, Descatoire V, Amouyal G, Letteron P, Geneve J, Larrey D, Pessayre D.

Biochem Pharmacol. 1987 Mar 15;36(6):951-5.

PMID:
3494453
36.

The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice.

Labbe G, Descatoire V, Letteron P, Degott C, Tinel M, Larrey D, Carrion-Pavlov Y, Geneve J, Amouyal G, Pessayre D.

Biochem Pharmacol. 1987 Mar 15;36(6):907-14.

PMID:
3105541
37.

Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding.

Geneve J, Degott C, Letteron P, Tinel M, Descatoire V, Larrey D, Amouyal G, Pessayre D.

Biochem Pharmacol. 1987 Feb 1;36(3):331-7.

PMID:
3814175
38.

Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding.

Geneve J, Larrey D, Letteron P, Descatoire V, Tinel M, Amouyal G, Pessayre D.

Biochem Pharmacol. 1987 Feb 1;36(3):323-9.

PMID:
3814174
39.

Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.

Letteron P, Descatoire V, Larrey D, DeGott C, Tinel M, Geneve J, Pessayre D.

J Pharmacol Exp Ther. 1986 Nov;239(2):559-67.

PMID:
3772810
40.

Inactivation and induction of cytochrome P-450 by various psoralen derivatives in rats.

Letteron P, Descatoire V, Larrey D, Tinel M, Geneve J, Pessayre D.

J Pharmacol Exp Ther. 1986 Aug;238(2):685-92.

PMID:
3735138
41.

Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters.

Larrey D, Tinel M, Letteron P, Geneve J, Descatoire V, Pessayre D.

Biochem Pharmacol. 1986 Jul 1;35(13):2213-20.

PMID:
3729976
42.

Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice.

Larrey D, Letteron P, Foliot A, Descatoire V, Degott C, Geneve J, Tinel M, Pessayre D.

J Pharmacol Exp Ther. 1986 Apr;237(1):283-91.

PMID:
3083096
43.

Inactivation of cytochrome P-450 by the drug methoxsalen.

Fouin-Fortunet H, Tinel M, Descatoire V, Letteron P, Larrey D, Geneve J, Pessayre D.

J Pharmacol Exp Ther. 1986 Jan;236(1):237-47.

PMID:
3941395
44.

Regulation of renal cytochrome P-450. Effects of two-thirds hepatectomy, cholestasis, biliary cirrhosis and post-necrotic cirrhosis on hepatic and renal microsomal enzymes.

Babany G, Descatoire V, Corbic M, Gendre S, Degott C, Larrey D, Letteron P, Wandscheer JC, Funck-Brentano C, Pessayre D.

Biochem Pharmacol. 1985 Feb 1;34(3):311-20.

PMID:
3918537
45.

Hepatotoxicity of trichloroethylene-carbon tetrachloride mixtures in rats. A possible consequence of the potentiation by trichloroethylene of carbon tetrachloride-induced lipid peroxidation and liver lesions.

Pessayre D, Cobert B, Descatoire V, Degott C, Babany G, Funck-Brentano C, Delaforge M, Larrey D.

Gastroenterology. 1982 Oct;83(4):761-72.

PMID:
7106507
46.

Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin.

Pessayre D, Descatoire V, Tinel M, Larrey D.

J Pharmacol Exp Ther. 1982 Apr;221(1):215-21. No abstract available.

PMID:
6977641
47.
48.

Hypoactivity of cytochrome P-450 after triacetyloleandomycin administration.

Pessayre D, Konstantinova-Mitcheva M, Descatoire V, Cobert B, Wandscheer JC, Level R, Feldmann G, Mansuy D, Benhamou JP.

Biochem Pharmacol. 1981 Mar 15;30(6):559-64. No abstract available.

PMID:
6973978
49.

Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450.

Pessayre D, Descatoire V, Konstantinova-Mitcheva M, Wandscheer JC, Cobert B, Level R, Benhamou PJ, Jaouen M, Mansuy D.

Biochem Pharmacol. 1981 Mar 15;30(6):553-8. No abstract available.

PMID:
6973977
50.

Cumulative effects of repeated doses of compounds transformed into reactive metabolites.

Pessayre D, Wandscheer JC, Descatoire V, Dolder A, Degott C, Benhamou JP.

Biochem Pharmacol. 1980 Apr 1;29(7):1041-7. No abstract available.

PMID:
7387721

Supplemental Content

Loading ...
Support Center